BEHAVIORAL DEPRESSION - OPPOSITE EFFECTS OF NEONATAL DEXAMETHASONE AND ACTH-(4-9) ANALOG (ORG 2766) TREATMENTS IN THE RAT

被引:17
|
作者
FELSZEGHY, K
SASVARI, M
NYAKAS, C
机构
[1] Central Research Division, Department of Clinical, Experimental Laboratory Investigations, Budapest
关键词
D O I
10.1006/hbeh.1993.1028
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Permanent changes in novelty-induced arousal and behavioral depression were studied in adult male Wistar rats having received sc injections of 1 μg/g body wt dexamethasone (DEX) or ACTH-(4-9) analogue (ORG 2766), or the combined treatment of these substances at Postnatal Days 1, 3, and 5. Treatment with DEX increased immobility in the Porsolt's water immersion and closed-field tests, delayed start latency, and attenuated orientation motility in an open-field, and enhanced defensive burying activity. On the contrary, the ACTH peptide caused more active behavior, resulted in an increased molility in the Porsolt's test, and decreased immobility in the closed-field chamber compared to controls. Behavioral reactivity of rats after combined DEX and ACTH peptide treatments was comparable to that of saline controls. The hormone treatments did not alter basal and stress-induced circulating corticosterone levels assessed at the adult age. The data suggest that neonatal DEX strengthens the development of brain mechanisms supporting behavioral depression in response to stressful situations, while ORG 2766 has principally an opposite effect and is able to compensate the longterm aberrant behavioral effects of neonatal DEX treatment. © 1993 by Academic Press, Inc.
引用
收藏
页码:380 / 396
页数:17
相关论文
共 50 条
  • [1] OPIOID SYSTEMS IN THE AMYGDALA CAN SERVE AS SUBSTRATE FOR THE BEHAVIORAL-EFFECTS OF THE ACTH-(4-9) ANALOG ORG-2766
    WOLTERINK, G
    VANREE, JM
    NEUROPEPTIDES, 1989, 14 (02) : 129 - 136
  • [2] Permanent upregulation of hippocampal mineralocorticoid receptors after neonatal administration of ACTH-(4-9) analog ORG 2766 in rats
    Nyakas, C
    Felszeghy, K
    Bohus, B
    Luiten, PGM
    DEVELOPMENTAL BRAIN RESEARCH, 1997, 99 (02): : 142 - 147
  • [3] NALTREXONE-SENSITIVE BEHAVIORAL ACTIONS OF THE ACTH 4-9 ANALOG (ORG 2766)
    FEKETE, M
    DRAGO, F
    VANREE, JM
    BOHUS, B
    WIEGANT, VM
    DEWIED, D
    LIFE SCIENCES, 1983, 32 (19) : 2193 - 2204
  • [4] THE ACTH-(4-9) ANALOG, ORG-2766, PREVENTS TAXOL-INDUCED NEUROPATHY IN RATS
    HAMERS, FPT
    PETTE, C
    NEIJT, JP
    GISPEN, WH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 233 (01) : 177 - 178
  • [5] AN ACTH-(4-9) ANALOG, ORG-2766, IMPROVES RECOVERY FROM ACRYLAMIDE NEUROPATHY IN RATS
    SPORELOZAKAT, RE
    EDWARDS, PM
    VANDERHOOP, RG
    GISPEN, WH
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 186 (2-3) : 181 - 187
  • [6] A controlled trial with ORG 2766, an ACTH-(4-9) analog, in 50 relatively able children with autism
    Buitelaar, JK
    Dekker, MEM
    vanRee, JM
    vanEngeland, H
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 (01) : 13 - 19
  • [7] ANALYSIS OF THE FACILITATORY EFFECT OF THE ACTH-(4-9) ANALOG ORG-2766 ON ACTIVE SOCIAL CONTACT IN RATS
    NIESINK, RJM
    VANREE, JM
    LIFE SCIENCES, 1984, 34 (10) : 961 - 970
  • [8] THE EFFECT OF THE ACTH-(4-9) ANALOG ORG-2766 ON ENVIRONMENTALLY INDUCED CHANGES IN MOTOR-ACTIVITY
    WOLTERINK, G
    VANREE, JM
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1984, 6 (05) : 227 - 227
  • [9] STRUCTURAL MODIFICATIONS OF THE ACTH-(4-9) ANALOG ORG-2766 YIELDS PEPTIDES WITH HIGH BIOLOGICAL-ACTIVITY
    WOLTERINK, G
    VANREE, JM
    VANNISPEN, JW
    DEWIED, D
    LIFE SCIENCES, 1991, 48 (02) : 155 - 161
  • [10] SOME EFFECTS OF AN ACTH 4-9 ANALOG (ORG-2766) ON HUMAN-PERFORMANCE
    GAILLARD, AWK
    VAREY, CA
    PHYSIOLOGY & BEHAVIOR, 1979, 23 (01) : 79 - 84